PTH and bortezomib suppress growth of primary human myeloma through increased bone formation in vivo.

被引：0
|
作者：
Pennisi, Angela [1 ]
Ling, Wen [1 ]
Perkins, Paul [1 ]
Saha, Rinku [1 ]
Li, Xin [1 ]
Barlogie, Bart [1 ]
Tricot, Guido [1 ]
Zangari, Maurizio [1 ]
Yaccoby, Shmuel [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Theraphy, Little Rock, AR 72205 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
509
引用
收藏
页码：154A / 154A
页数：1
相关论文
共 50 条
  • [21] Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche
    Zhang, Wenting
    Gu, Yexin
    Sun, Qiaoling
    Siegel, David S.
    Tolias, Peter
    Yang, Zheng
    Lee, Woo Y.
    Zilberberg, Jenny
    PLOS ONE, 2015, 10 (05):
  • [22] Neonatal Mouse Bone Supports Growth Of Primary Myeloma Cells Ex Vivo and Assessment Of Responses To Antimyeloma Drugs
    Suvannasankha, Attaya
    Tompkins, Douglas R.
    Petyaykina, Kateryna
    Crean, Colin D.
    Condon, Keith W.
    Roodman, G. David David
    Chirgwin, John M.
    BLOOD, 2013, 122 (21)
  • [23] Human Bone Marrow-Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis
    Ho, Ivy A. W.
    Toh, Han C.
    Ng, Wai H.
    Teo, Yuan L.
    Guo, Chang M.
    Hui, Kam M.
    Lam, Paula Y. P.
    STEM CELLS, 2013, 31 (01) : 146 - 155
  • [24] Combination of the proteasome inhibitor bortezomib and a histone deacetylase inhibitor PXD101 results in synergistic inhibition of osteoclastogenesis and significantly stronger inhibition of multiple myeloma growth in vitro and in vivo.
    Feng, Rentian
    Oton, Ana B.
    Patrene, Kenneth
    Anderson, Gulsum
    Mapara, Markus Y.
    Belani, Chandra
    Roodman, David
    Lentzsch, Suzanne
    BLOOD, 2006, 108 (11) : 153A - 154A
  • [25] Increased Signaling Through p62 in the Multiple Myeloma Microenvironment Increases Myeloma (MM) Cell Growth and Osteoclast (OCL) Formation
    Hiruma, Y.
    Kurihara, N.
    Roodman, G. D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S188 - S188
  • [26] THE ANABOLIC EFFECT OF HUMAN PTH(1-34) ON BONE-FORMATION IS BLUNTED WHEN BONE-RESORPTION IS INHIBITED BY THE BISPHOSPHONATE TILUDRONATE - IS ACTIVATED RESORPTION A PREREQUISITE FOR THE IN-VIVO EFFECT OF PTH ON FORMATION IN A REMODELING SYSTEM
    DELMAS, PD
    VERGNAUD, P
    ARLOT, ME
    PASTOUREAU, P
    MEUNIER, PJ
    NILSSEN, MHL
    BONE, 1995, 16 (06) : 603 - 610
  • [27] Blocking macrophage inflammatory protein-1-alpha in myeloma cells decreases bone destruction and tumor burden by decreasing their homing capacity and growth in vivo.
    Choi, SJ
    Oba, Y
    Anderson, JL
    Roodman, GD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S224 - S224
  • [28] Increased Signaling through p62 in the Marrow Microenvironment Increases Myeloma Cell Growth and Osteoclast Formation
    Hiruma, Yuko
    Kurihara, Noriyoshi
    Jelinek, Diane F.
    Roodman, David
    BLOOD, 2008, 112 (11) : 239 - 239
  • [29] Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation
    Hiruma, Yuko
    Honjo, Tadashi
    Jelinek, Diane F.
    Windle, Jolene J.
    Shin, Jaekyoon
    Roodman, G. David
    Kurihara, Noriyoshi
    BLOOD, 2009, 113 (20) : 4894 - 4902
  • [30] Increased Expression of TAF12 in Myeloma Cells and the Bone Microenvironment Enhances Tumor Cell Growth and Osteoclast Formation
    Kurihara, Noriyoshi
    Teramachi, Jumpei
    Kitagawa, Yukiko
    Chirgwin, John
    Roodman, G. David
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
12345